- Botulinum toxin injections for the treatment of spasmodic dysphonia
- Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
- Botulinum toxin type A therapy for blepharospasm
- Botulinum toxin type A therapy for cervical dystonia
- Botulinum toxin type A therapy for hemifacial spasm
- Botulinum toxin type A versus anticholinergics for cervical dystonia
- Botulinum toxin type A versus botulinum toxin type B for cervical dystonia
- Botulinum toxin type B for cervical dystonia
- Bradykinin beta‐2 receptor antagonists for acute traumatic brain injury
- Bromperidol decanoate (depot) for schizophrenia
- Budesonide for induction of remission in Crohn's disease
- Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
- Caffeine as an analgesic adjuvant for acute pain in adults
- Caffeine for asthma
- Caffeine versus theophylline for apnea in preterm infants
- Calcitonin for preventing and treating corticosteroid‐induced osteoporosis
- Calcium and vitamin D for corticosteroid‐induced osteoporosis
- Calcium channel blockers for acute traumatic brain injury
- Calcium channel blockers for antipsychotic‐induced tardive dyskinesia
- Calcium channel blockers for inhibiting preterm labour and birth
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.